Safety Study of SEA-CD40 in Cancer Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Schmitt, MD, PhD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Honorhealth Scottsdale Shea Medical Center
Scottsdale, Arizona, United States
- Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California, United States
- Angeles Clinic and Research Institute, the
Santa Monica, California, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Karmanos Cancer Institute / Wayne State University
Detroit, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Unc Lineberger Comprehensive Cancer Center / University of North Carolina
Chapel Hill, North Carolina, United States
- Case Western Reserve University / University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- Md Anderson Cancer Center / University of Texas
Houston, Texas, United States
- Utah Cancer Specialists
Salt Lake City, Utah, United States
- Seattle Cancer Care Alliance / University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2015
- Primary completion
- 6 Mar 2023
- Completion
- 14 Apr 2023
- Last update posted
- 1 May 2023
- Registered enrollment
- 159
- Registry id
- NCT02376699
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.